Party hosts have an important role to play in keeping Big Game festivities and other social gatherings fun and allergy-friendly. For allergy-friendly Big Game party recipes, visit http://auvi-q.com/tools-and-downloads. For Jerome's and Robin's allergy-friendly entertaining tips, visit http://www.multivu.com/assets/59439/documents/59439-allergy-friendly-entertaining-tips-original.pdf.
Auvi-Q provides users with audible and visual cues, including a five-second injection countdown and an alert light to signal when the injection is complete. In addition to being an auto-injector, Auvi-Q features an automatic retractable needle mechanism to help prevent accidental needle sticks.
Available in two different dosages, Auvi-Q 0.3mg delivers 0.3mg epinephrine injection and is intended for patients who weigh 66 pounds or more. Auvi-Q 0.15mg delivers 0.15mg epinephrine injection and is intended for patients who weigh 33 – 66 pounds.
Auvi-Q has not been studied in patients weighing less than 33 pounds. Each Auvi-Q pack contains two devices - containing one dose of epinephrine each - and a non-active training device.
Auvi-Q received U.S. Food and Drug Administration approval in
Eric and Evan Edwards
, twin brothers who suffer from life-threatening allergies, and co-founders of Intelliject, Inc., developed Auvi-Q with a team of world class engineers and scientists. The development process incorporated real-world experiences and feedback from patients and caregivers. Sanofi US licensed the
commercialization rights to Auvi-Q from Intelliject, Inc., which has retained commercialization rights for the rest of the world.
Auvi-Q has been named an International CES Innovations 2013 Design and Engineering Awards Honoree.
The prestigious Innovations Design and Engineering Awards are sponsored by the Consumer Electronics Association (CEA)
, the producer of the International CES and the world's largest consumer technology tradeshow.
For more information about Auvi-Q, visit